These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 34235656)

  • 1. Drug Susceptibility Screening Using In Vitro Models of Hypoxic Non-Replicating Persistent Mycobacteria.
    Gibson SER; Harrison J; Cox JAG
    Methods Mol Biol; 2021; 2314():247-260. PubMed ID: 34235656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-oxygen-recovery assay for high-throughput screening of compounds against nonreplicating Mycobacterium tuberculosis.
    Cho SH; Warit S; Wan B; Hwang CH; Pauli GF; Franzblau SG
    Antimicrob Agents Chemother; 2007 Apr; 51(4):1380-5. PubMed ID: 17210775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cholesterol-dependent activity of dapsone against non-replicating persistent mycobacteria.
    Gibson SER; Harrison J; Molloy A; Cox JAG
    Microbiology (Reading); 2022 Dec; 168(12):. PubMed ID: 36748615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein kinase G confers survival advantage to
    Khan MZ; Bhaskar A; Upadhyay S; Kumari P; Rajmani RS; Jain P; Singh A; Kumar D; Bhavesh NS; Nandicoori VK
    J Biol Chem; 2017 Sep; 292(39):16093-16108. PubMed ID: 28821621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Multistress Model for High Throughput Screening Against Nonreplicating Mycobacterium tuberculosis.
    Gold B; Warrier T; Nathan C
    Methods Mol Biol; 2021; 2314():611-635. PubMed ID: 34235673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of model systems to study adaptive responses of Mycobacterium tuberculosis during infection and disease.
    Gordhan BG; Peters J; Kana BD
    Adv Appl Microbiol; 2019; 108():115-161. PubMed ID: 31495404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A mathematical representation of the development of Mycobacterium tuberculosis active, latent and dormant stages.
    Magombedze G; Mulder N
    J Theor Biol; 2012 Jan; 292():44-59. PubMed ID: 21968442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxygen Modulates the Effectiveness of Granuloma Mediated Host Response to Mycobacterium tuberculosis: A Multiscale Computational Biology Approach.
    Sershen CL; Plimpton SJ; May EE
    Front Cell Infect Microbiol; 2016; 6():6. PubMed ID: 26913242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A multi-stress model for high throughput screening against non-replicating Mycobacterium tuberculosis.
    Gold B; Warrier T; Nathan C
    Methods Mol Biol; 2015; 1285():293-315. PubMed ID: 25779324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of BACTEC 460 TB system for rapid in vitro screening of drugs against latent state Mycobacterium tuberculosis H37Rv under hypoxia conditions.
    Kharatmal S; Jhamb SS; Singh PP
    J Microbiol Methods; 2009 Aug; 78(2):161-4. PubMed ID: 19454297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonreplicating persistence of mycobacterium tuberculosis.
    Wayne LG; Sohaskey CD
    Annu Rev Microbiol; 2001; 55():139-63. PubMed ID: 11544352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypoxic Non-replicating Persistent
    Jakkala K; Ajitkumar P
    Front Microbiol; 2019; 10():2339. PubMed ID: 31681204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro models that utilize hypoxia to induce non-replicating persistence in Mycobacteria.
    Sohaskey CD; Voskuil MI
    Methods Mol Biol; 2015; 1285():201-13. PubMed ID: 25779317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ICAT-based comparative proteomic analysis of non-replicating persistent Mycobacterium tuberculosis.
    Cho SH; Goodlett D; Franzblau S
    Tuberculosis (Edinb); 2006 Nov; 86(6):445-60. PubMed ID: 16376151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Caseum: a Niche for Mycobacterium tuberculosis Drug-Tolerant Persisters.
    Sarathy JP; Dartois V
    Clin Microbiol Rev; 2020 Jun; 33(3):. PubMed ID: 32238365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Universal Stress Protein That Controls Bacterial Stress Survival in Micrococcus luteus.
    Havis S; Bodunrin A; Rangel J; Zimmerer R; Murphy J; Storey JD; Duong TD; Mistretta B; Gunaratne P; Widger WR; Bark SJ
    J Bacteriol; 2019 Dec; 201(24):. PubMed ID: 31548273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modelling a Silent Epidemic: A Review of the In Vitro Models of Latent Tuberculosis.
    Gibson SER; Harrison J; Cox JAG
    Pathogens; 2018 Nov; 7(4):. PubMed ID: 30445695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A high content screening assay for identifying inhibitors against active and dormant state intracellular Mycobacterium tuberculosis.
    Yeware A; Agrawal S; Sarkar D
    J Microbiol Methods; 2019 Sep; 164():105687. PubMed ID: 31415793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strategies in anti-Mycobacterium tuberculosis drug discovery based on phenotypic screening.
    Grzelak EM; Choules MP; Gao W; Cai G; Wan B; Wang Y; McAlpine JB; Cheng J; Jin Y; Lee H; Suh JW; Pauli GF; Franzblau SG; Jaki BU; Cho S
    J Antibiot (Tokyo); 2019 Oct; 72(10):719-728. PubMed ID: 31292530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel red fluorescence protein based microplate assay for drug screening against dormant Mycobacterium tuberculosis by using paraffin.
    Yeware A; Sarkar D
    Tuberculosis (Edinb); 2018 May; 110():15-19. PubMed ID: 29779767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.